Page last updated: 2024-09-05

anacardic acid and Breast Neoplasms

anacardic acid has been researched along with Breast Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (83.33)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Gnanaprakasam, JNR; López-Bañuelos, L; Vega, L1
Alizadeh-Rad, N; Green, MA; Klinge, CM; Muluhngwi, P; Rouchka, EC; Schultz, DJ; Waigel, SJ1
Dora, CP; Gupta, RC; Jain, S; Katiyar, SS; Kumar Agrawal, A; Kushwah, V; Lamprou, DA1
Ghadi, R; Jain, S; Katiyar, SS; Kushwah, V; Rege, MD1
Huo, Q; Li, H; Liu, H; Ma, T; Nie, L; Wu, C; Zhao, S1
Chen, C; Cunningham, AR; Dougherty, SM; Imbert-Fernandez, Y; Isaacs, SM; Ivanova, MM; Klinge, CM; Schultz, DJ; Wickramasinghe, NS1

Other Studies

6 other study(ies) available for anacardic acid and Breast Neoplasms

ArticleYear
Anacardic 6-pentadecyl salicylic acid induces apoptosis in breast cancer tumor cells, immunostimulation in the host and decreases blood toxic effects of taxol in an animal model.
    Toxicology and applied pharmacology, 2021, 01-01, Volume: 410

    Topics: Anacardic Acids; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; Immunity, Cellular; Immunization; Leukocytes, Mononuclear; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Paclitaxel

2021
Genome-wide miRNA response to anacardic acid in breast cancer cells.
    PloS one, 2017, Volume: 12, Issue:9

    Topics: Anacardic Acids; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Cluster Analysis; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genome-Wide Association Study; Humans; MicroRNAs; RNA Interference; RNA, Messenger; Transcriptome

2017
Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
    Acta biomaterialia, 2018, Volume: 73

    Topics: Albumins; Anacardic Acids; Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Clathrin; Deoxycytidine; Docetaxel; Drug Carriers; Female; Gemcitabine; Hemolysis; Humans; Macromolecular Substances; MCF-7 Cells; Nanoparticles; Neoplasm Transplantation; Particle Size; Polymers; Protein Conformation; Rats; Rats, Sprague-Dawley

2018
Exploring an interesting dual functionality of anacardic acid for efficient paclitaxel delivery in breast cancer therapy.
    Nanomedicine (London, England), 2019, Volume: 14, Issue:1

    Topics: Anacardic Acids; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Survival; Drug Carriers; Drug Compounding; Drug Liberation; Female; Gelatin; Humans; Hydrophobic and Hydrophilic Interactions; MCF-7 Cells; Nanoparticles; Paclitaxel; Particle Size; Rats, Sprague-Dawley; Surface Properties

2019
[Effect of anacardic acid, a Hsp90 inhibitor, on proliferation, invasion and migration of breast cancer MDA-MB-231 cells].
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2015, Volume: 35, Issue:3

    Topics: Anacardic Acids; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Down-Regulation; HSP90 Heat-Shock Proteins; Humans; Matrix Metalloproteinase 9; Tissue Inhibitor of Metalloproteinase-1

2015
Anacardic acid inhibits estrogen receptor alpha-DNA binding and reduces target gene transcription and breast cancer cell proliferation.
    Molecular cancer therapeutics, 2010, Volume: 9, Issue:3

    Topics: Anacardic Acids; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Proliferation; DNA; Down-Regulation; Estrogen Receptor alpha; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Protein Binding; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Cells, Cultured

2010